BIOLINERX     Print Page  Close Window

SEC filings
424B5
BIOLINERX LTD. filed this Form 424B5 on 07/26/2017
Entire Document
 

DESCRIPTION OF WARRANTS
 
We may issue warrants for the purchase of our ADSs. We may issue warrants independently of or together with ordinary shares (including ordinary shares represented by ADSs) offered by any prospectus supplement, and we may attach the warrants to, or issue them separately from, ordinary shares (including ordinary shares represented by ADSs). Each series of warrants will be issued under a separate warrant agreement to be entered into between us and a bank or trust company, as warrant agent, all as set forth in the prospectus supplement relating to the particular issue of offered warrants. The warrant agent will act solely as our agent in connection with the warrant certificates relating to the warrants and will not assume any obligation or relationship of agency or trust with any holders of warrant certificates or beneficial owners of warrants. The following summaries of certain provisions of the warrant agreements and warrants do not purport to be complete and are subject to, and are qualified in their entirety by reference to, all the provisions of the warrant agreement and the warrant certificates relating to each series of warrants which we will file with the SEC and incorporate by reference as an exhibit to the registration statement of which this prospectus is a part at or prior to the time of the issuance of any series of warrants.
 
General
 
The applicable prospectus supplement will describe the terms of the warrants, including as applicable:
 
the offering price;
 
the aggregate number or amount of underlying securities purchasable upon exercise of the warrants and the exercise price;
 
the number of warrants being offered;
 
the date, if any, after which the warrants and the underlying securities will be transferable separately;
 
the date on which the right to exercise the warrants will commence, and the date on which the right will expire (the “Expiration Date”);
 
the number of warrants outstanding, if any;
 
any material Israeli and/or U.S. federal income tax consequences;
 
the terms, if any, on which we may accelerate the date by which the warrants must be exercised; and
 
any other terms of the warrants, including terms, procedures and limitations relating to the exchange and exercise of the warrants.
 
Warrants will be offered and exercisable for US dollars only and will be in registered form only.
 
Holders of warrants will be able to exchange warrant certificates for new warrant certificates of different denominations, present warrants for registration of transfer, and exercise warrants at the corporate trust office of the warrant agent or any other office indicated in the applicable prospectus supplement. Prior to the exercise of any warrants, holders of the warrants to purchase ordinary shares will not have any rights of holders of ordinary shares, including the right to receive payments of dividends, if any, or to exercise any applicable right to vote.
 
35